Dupixent 200 mg solution for injection in pre-filled pen, Tezspire 210 mg solution for injection in pre-filled syringe clinical trials

Direct comparison of Tezepelumab and Dupilumab in CRSwNP in a real world setting

This study compares two medicines, Dupixent and Tezspire, for treating long-term nasal polyps. Researchers want to see which medicine works better in real-world use to improve symptoms like stuffy nose and sense of smell over 12 months.